[A randomized controlled trial of metastases-directed treatment in patients with metastatic prostate cancer using stereotactic body irradiation: A GETUG-AFU trial].

Authors :: Blanchard P
Foulon S
Louvel G
Habibian M
Fizazi K
Source :: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique [Cancer Radiother] 2017 Oct; Vol. 21 (6-7), pp. 491-494. Date of Electronic Publication: 2017 Aug 30.
Publication Year :: 2017
Abstract: The goal of treatment of metastatic prostate cancer remains palliation. The oligometastatic state could be the right time to intensify therapy by introducing metastases directed treatments. The aim of this trial was to evaluate the benefit of radiotherapy to all macroscopic metastatic sites and to the primary disease in patients with hormone sensitive oligometastatic prostate cancer.<br /> (Copyright © 2017 Société française de radiothérapie oncologique (SFRO). Published by Elsevier SAS. All rights reserved.)

Subjects :: Humans
Male
Neoplasm Metastasis
Research Design
Bone Neoplasms radiotherapy
Bone Neoplasms secondary
Lymphatic Irradiation
Prostatic Neoplasms pathology
Prostatic Neoplasms radiotherapy
Radiosurgery

Language :: French
ISSN :: 1769-6658
Volume :: 21
Issue :: 6-7
Database :: MEDLINE
Journal :: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Publication Type :: Academic Journal
Accession number :: 28869198
Full Text :: https://doi.org/10.1016/j.canrad.2017.06.007

Full Text Access

Tools